Answers are grounded in this paper and cite their sources.
Reveals coding issues in fungal disease estimates in the United States, suggesting a need for improved practices.
Fungal diseases are frequently coded as “unspecified mycoses” in data sets used to estimate disease burden. In a large administrative database, 50.9% of unspecified mycosis hospitalizations during 2019–2021 had positive fungal laboratory testing, most commonly Candida (79.1%), highlighting a potential need for improved coding practices and greater fungal laboratory testing.
No takes yet. Share an insight, caveat, or question.
Benedict et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: